Most drug development organizations have two basic needs. The first need is to standardize the reporting and second, to streamline the reporting process. SAS-generated reports are a key component of most clinical study reports that are included in a regulatory submission. The reporting of most clinical data is similar from study to study and therefore can be standardized. This standardization creates an opportunity for SAS macro-driven reporting.